Atricure Stock Performance
| ATRC Stock | USD 41.04 1.34 3.16% |
On a scale of 0 to 100, AtriCure holds a performance score of 8. The firm shows a Beta (market volatility) of 1.08, which signifies a somewhat significant risk relative to the market. AtriCure returns are very sensitive to returns on the market. As the market goes up or down, AtriCure is expected to follow. Please check AtriCure's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether AtriCure's price patterns will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, AtriCure exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (3.14) | Five Day Return (1.32) | Year To Date Return 35.03 | Ten Year Return 89.43 | All Time Return 191.55 |
1 | AtriCure to Announce Third Quarter 2025 Financial Results | 10/08/2025 |
2 | AtriCure enrolls first patient in BoxX-NoAF clinical trial ATRC | 10/28/2025 |
3 | Heres What Key Metrics Tell Us About AtriCure Q3 Earnings | 11/06/2025 |
4 | Is AtriCure Stock Outpacing Its Medical Peers This Year | 11/20/2025 |
5 | Head-To-Head Comparison AtriCure versus PositiveID | 11/21/2025 |
6 | Disposition of 5033 shares by Wehrwein Sven of AtriCure at 19.95 subject to Rule 16b-3 | 11/24/2025 |
7 | Wall Street Analysts Believe AtriCure Could Rally 36.3 percent Heres is How to Trade | 11/25/2025 |
8 | AtriCure, Inc. ATRC Shares Sold by Intech Investment Management LLC | 11/26/2025 |
9 | Justin Noznesky Sells 5,166 Shares of AtriCure Stock | 11/28/2025 |
10 | Is It Time To Reassess AtriCure After Its Recent Share Price Rebound In 2025 | 12/03/2025 |
11 | Are Medical Stocks Lagging AtriCure This Year | 12/08/2025 |
12 | Disposition of 4000 shares by Michael Carrel of AtriCure subject to Rule 16b-3 | 12/10/2025 |
13 | AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating | 12/11/2025 |
| Begin Period Cash Flow | 84.3 M | |
| Total Cashflows From Investing Activities | 30.2 M |
AtriCure Relative Risk vs. Return Landscape
If you would invest 3,501 in AtriCure on September 17, 2025 and sell it today you would earn a total of 603.00 from holding AtriCure or generate 17.22% return on investment over 90 days. AtriCure is currently generating 0.291% in daily expected returns and assumes 2.8111% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of stocks are less volatile than AtriCure, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AtriCure Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AtriCure's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AtriCure, and traders can use it to determine the average amount a AtriCure's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1035
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATRC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average AtriCure is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AtriCure by adding it to a well-diversified portfolio.
AtriCure Fundamentals Growth
AtriCure Stock prices reflect investors' perceptions of the future prospects and financial health of AtriCure, and AtriCure fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AtriCure Stock performance.
| Return On Equity | -0.0611 | ||||
| Return On Asset | -0.0265 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0 % | ||||
| Current Valuation | 2.04 B | ||||
| Shares Outstanding | 49.72 M | ||||
| Price To Earning | 33.47 X | ||||
| Price To Book | 4.42 X | ||||
| Price To Sales | 3.94 X | ||||
| Revenue | 465.31 M | ||||
| Gross Profit | 388.06 M | ||||
| EBITDA | (18.53 M) | ||||
| Net Income | (44.7 M) | ||||
| Cash And Equivalents | 118.45 M | ||||
| Cash Per Share | 2.55 X | ||||
| Total Debt | 76.53 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | 9.59 X | ||||
| Cash Flow From Operations | 12.2 M | ||||
| Earnings Per Share | (0.59) X | ||||
| Market Capitalization | 2.04 B | ||||
| Total Asset | 609.33 M | ||||
| Retained Earnings | (401.75 M) | ||||
| Working Capital | 194.4 M | ||||
| Current Asset | 74.75 M | ||||
| Current Liabilities | 31.59 M | ||||
About AtriCure Performance
By analyzing AtriCure's fundamental ratios, stakeholders can gain valuable insights into AtriCure's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AtriCure has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AtriCure has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 233.46 | 133.18 | |
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.07) | (0.08) | |
| Return On Equity | (0.10) | (0.10) |
Things to note about AtriCure performance evaluation
Checking the ongoing alerts about AtriCure for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AtriCure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the previous year's revenue of 465.31 M. Net Loss for the year was (44.7 M) with profit before overhead, payroll, taxes, and interest of 388.06 M. | |
| Over 100.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from investors.com: AtriCure Clears Technical Benchmark, Hitting 80-Plus RS Rating |
- Analyzing AtriCure's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AtriCure's stock is overvalued or undervalued compared to its peers.
- Examining AtriCure's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AtriCure's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AtriCure's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AtriCure's stock. These opinions can provide insight into AtriCure's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |